Local control and radionecrosis of brain metastases from non-small-cell lung cancer treated by hypofractionated stereotactic radiotherapy: Evaluation of predictive factors - Université Clermont Auvergne Accéder directement au contenu
Article Dans Une Revue Clinical and Translational Radiation Oncology Année : 2022

Local control and radionecrosis of brain metastases from non-small-cell lung cancer treated by hypofractionated stereotactic radiotherapy: Evaluation of predictive factors

Résumé

The objective of our study was to report predictive factors of local control (LC) and radionecrosis (RN) of brain metastases (BM) of non-small cell lung carcinoma (NSCLC) treated by multifractionated stereotactic radiotherapy (MF-SRT) according to French recommendations.

Dates et versions

Identifiants

Citer

Brice Leyrat, Toufic Khalill, Jean-Jacques Lemaire, Melanie Casile, Ioana Molnar, et al.. Local control and radionecrosis of brain metastases from non-small-cell lung cancer treated by hypofractionated stereotactic radiotherapy: Evaluation of predictive factors. Clinical and Translational Radiation Oncology, 2022, 36, pp.1-8. ⟨10.1016/j.ctro.2022.05.008⟩. ⟨hal-03889468⟩
16 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More